The UK's largest public-private initiative targeting early-stage antimicrobial drug and diagnostic discovery has been introduced by Innovate UK, LifeArc and Medicines Discovery Catapult (MDC). Click to read more.
Innovate UK joins forces with LifeArc and Medicines Discovery Catapult to accelerate early-stage innovation in antimicrobial resistance (AMR). Innovate UK and medical research organisation LifeArc, have each invested £15 million in PACE (Pathways to Antimicrobial Clinical Efficacy), which will be delivered by Medicines Discovery Catapult. PACE will focus on removing barriers and connecting the AMR ecosystem to accelerate and strengthen the pre-clinical AMR pipeline.
UK Gov Pumps £200M into Zero-Emission Truck Innovation miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.